News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current RDHL market cap is 0. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 13.21M | 17.55M | 12.8M | 42.68M | 5.71M |
| Operating Income | -12.55M | -7.11M | -9.95M | 29.08M | -4.41M |
| Net Income | -15.1M | -35.7M | -3.73M | 50.24M | 761k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 6.29M | 64.36M | 85.76M | 61.8M | 50.59M |
| Operating Income | -43.2M | -63.68M | -81.14M | -42.84M | 12.63M |
| Net Income | -42.3M | -76.17M | -97.74M | -71.67M | 23.92M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 167.97M | 157.19M | 158.87M | 58.83M | 35.04M |
| Total Liabilities | 179.91M | 203.22M | 207.27M | 56.83M | 31.57M |
| Total Equity | -11.94M | -46.03M | -48.4M | 2M | 3.47M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 74.1M | 180.24M | 181.19M | 158.87M | 23.05M |
| Total Liabilities | 14.1M | 166.38M | 172.31M | 207.27M | 20.98M |
| Total Equity | 60M | 13.86M | 8.88M | -48.4M | 2.07M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -20.74M | -26.76M | -29.19M | -7.19M | -17.78M |
| Investing | 8.32M | 8.3M | 8.3M | N/A | -7k |
| Financing | 9.97M | 4.25M | 11.45M | 4.81M | 4.81M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -40.75M | -48.58M | -65.05M | -29.19M | -35.82M |
| Investing | 5.16M | -35.65M | -8.14M | 8.3M | 4k |
| Financing | 35.51M | 84.37M | 73.46M | 11.45M | 21.44M |
| Market Cap | 0 |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 0 |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.01 (3.36%) |
| Company Name | Redhill Biopharma Ltd |
| Address |
21 ha’arba’a street tel aviv, center 64739 |
| Website | https://www.redhillbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
